SB-101 (Satellite Bio)

N/A

Report date: 2026/05/07 17:15:32

Base Information

Drug NameSB-101 (Satellite Bio)
Drug Alias NameSB-101SB-101 (Satellite Bio)
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Hepatocytes therapy
Mechanisms of ActionHepatocyte replacements
TargetsUpdating
Therapy Area/IndicationsUrea Cycle Disorders, Inborn
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSatellite Biosciences Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsUrea Cycle Disorders, Inborn
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A